A controlled comparative study of chlorprothixene vs. haloperidol in chronic schizophrenia.
Article Details
- CitationCopy to clipboard
Fux M, Belmaker RH
A controlled comparative study of chlorprothixene vs. haloperidol in chronic schizophrenia.
Isr J Psychiatry Relat Sci. 1991;28(1):37-40.
- PubMed ID
- 1830565 [ View in PubMed]
- Abstract
Neurochemical distinctions have been made between neuroleptic drugs that affect D-1 receptors as well as D-2 receptors, compared with those neuroleptic drugs that affect only D-2 receptors. However, a controlled double-blind study of haloperidol vs. chlorprothixene in schizophrenic patients found no significant differences.
DrugBank Data that Cites this Article
- Drug Targets
Drug Target Kind Organism Pharmacological Action Actions Chlorprothixene Dopamine D1 receptor Protein Humans YesAntagonistDetails Chlorprothixene Dopamine D2 receptor Protein Humans YesAntagonistDetails Chlorprothixene Dopamine D3 receptor Protein Humans YesAntagonistDetails